Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Adverse effects
RCT	42 people with advanced terminal cancer, all receiving haloperidol, metoclopramide, or both	Adverse effects with hypodermoclysis with no artificial hydration Absolute results not reported